GLP-1 RA Reduces Severity of Steatotic Liver Disease in People With HIV
MONDAY, March 18, 2024 -- For people with HIV (PWH) with metabolic-associated steatotic liver disease (MASLD), semaglutide is associated with absolute and relative declines in intrahepatic triglyceride (IHTG) content, according to a study presented... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 18, 2024 Category: Pharmaceuticals Source Type: news

Mirimus' RNAi Technology Helps Advance New Treatment for Liver Tumors and Acute Chronic Liver Diseases
Leveraging Mirimus RNAi technology, a study led by Tuebingen University shows that a new drug has the potential to revolutionize liver surgery and liver transplantation. NEW YORK, March 18, 2024 /PRNewswire-PRWeb/ -- Mirimus, a pioneer in RNAi therapeutic design and CRISPR/Cas9 gene... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 18, 2024 Category: Pharmaceuticals Tags: TRI Source Type: news

Chinese Scientists Implant First Pig Liver Into Brain-Dead Human
Who says nothing interesting ever happens in the world anymore? This week, in a "first of its kind" operation, a brain-dead human subject was implanted with the world's first gene-edited pig liver transplant, according to SCMP. In…#scmp (Source: Reuters: Health)
Source: Reuters: Health - March 16, 2024 Category: Consumer Health News Source Type: news

She beat a rare liver cancer – and now works with her father to find more cures
Cancer scientist decides to study the tumour that once afflicted his small daughter – and now her work is adding to his project’s successElana Simon was 10 years old when she started to experience severe pains in her abdomen. For two years, puzzled doctors put forward diagnoses including lactose intolerance, Crohn ’s disease and stress. It was not until 2008 that they pinpointed the real cause. Elana was suffering from fibrolamellar carcinoma(FLC), a rare, usually lethal, form of liver cancer.“In a way, it was comforting to have a word for what was wrong with me after so much confusion about my condition,” Elana ...
Source: Guardian Unlimited Science - March 16, 2024 Category: Science Authors: Robin McKie Science Editor Tags: Cancer research Medical research Science UK news Source Type: news

Madrigal wins first U.S. approval for drug to treat liver disease MASH
The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH. The pill, called Rezdiffra, is made by Madrigal Pharmaceuticals. Metabolic…#rezdiffra #metabolic (Source: Reuters: Health)
Source: Reuters: Health - March 16, 2024 Category: Consumer Health News Source Type: news

FDA approves first drug for common form of liver inflammation
The US Food and Drug Administration has approved the first medication for a common form of liver inflammation called nonalcoholic steatohepatitis, or NASH, the agency said Thursday. NASH — also known as metabolic dysfunction-associated steatohepatitis, or MASH — happens when the liver becomes…#nash #fda #rezdiffra #breakthroughtherapy #wayneeskridge #fattyliverfoundation #madrigal #pierregholam #universityhospitals #cleveland (Source: Reuters: Health)
Source: Reuters: Health - March 15, 2024 Category: Consumer Health News Source Type: news

FDA Approves First Drug for Common, Serious Liver Disease, Rezdiffra
FRIDAY, March 15, 2024 -- Millions of Americans whose livers develop scar tissue due to a common disease now have the first approved drug, Rezdiffra, to treat the condition, the U.S. Food and Drug Administration announced Thursday. The condition is... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 15, 2024 Category: General Medicine Source Type: news

Waterborne Parasite That Can Kill Dogs Is Spreading to U.S. West
FRIDAY, March 15, 2024 -- A parasite that can kill dogs has been found in a portion of the Colorado River that runs through Southern California. Heterobilharzia americana is a flatworm usually referred as liver fluke. It has never been reported... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 15, 2024 Category: General Medicine Source Type: news

FAPI-PET/CT outperforms FDG-PET/CT in women with invasive breast cancer
This study underscores Ga-68 FAPI-PET/CT’s superiority over F-18 FDG-PET/CT for ILC,” the group concluded. A link to the full study can be found here. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 15, 2024 Category: Radiology Authors: Will Morton Tags: Breast Source Type: news

US FDA approves first drug for fatty liver disease NASH
(Source: Reuters: Health)
Source: Reuters: Health - March 15, 2024 Category: Consumer Health News Source Type: news

FDA Approves First Drug for MASH FDA Approves First Drug for MASH
Resmetirom, a thyroid hormone receptor beta-selective agonist, is the first FDA-approved medication for MASH with moderate to advanced liver fibrosis.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - March 14, 2024 Category: Internal Medicine Tags: Gastroenterology Source Type: news

Shares of Madrigal Pharmaceuticals soar on FDA approval for NASH treatment
Conshohocken-based Madrigal Pharmaceutical has emerged as the winner in the race to be the first drug company to secure approval for a treatment targeting a liver disease known as NASH. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 14, 2024 Category: Biotechnology Authors: John George Source Type: news

FDA Approves First Treatment for Patients with Liver Scarring Due to Fatty Liver Disease
The FDA approved the first medication for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver scarring, to be used along with diet and exercise. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 14, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Approves First-Ever Drug for Serious Liver Condition
(MedPage Today) -- The FDA granted accelerated approval to resmetirom (Rezdiffra) as the first treatment for adults with noncirrhotic non-alcoholic steatohepatitis (NASH), also now referred to as metabolic dysfunction-associated steatohepatitis... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 14, 2024 Category: American Health Source Type: news

Konica Minolta applauds winner, runners up of SPIE research award
Konica Minolta Healthcare Americas congratulates the winner and runners-up of the Best Student Paper Award given by the International Society for Optics and Photonics (SPIE) at its 2024 Medical Imaging Symposium in San Diego, CA. Konica Minolta sponsored the award as part of its continued commitment to the education and support of young scientists in medical imaging. The winner was Olivia F. Sandvold, a doctoral student in the Department of Bioengineering at the University of Pennsylvania for her paper, “Hybrid spectral CT system with clinical rapid kVp-switching x-ray tube and dual-layer detector for improved iodin...
Source: AuntMinnie.com Headlines - March 14, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news